Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
West Pharmaceutical Services, Inc. (WST) had Return on Equity of 4.50% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$766.50M |
|
$131.80M |
|
$492.60M |
|
$273.90M |
|
$612.80M |
|
$153.70M |
|
$3.30M |
|
$157.00M |
|
$157.00M |
|
$126.80M |
|
$131.80M |
|
$131.80M |
|
$126.80M |
|
$153.70M |
|
$195.10M |
|
72.20M |
|
72.50M |
|
$1.82 |
|
$1.82 |
|
| Balance Sheet Financials | |
$1.68B |
|
$1.72B |
|
$2.27B |
|
$3.95B |
|
$604.60M |
|
$202.60M |
|
$419.10M |
|
$1.02B |
|
$2.93B |
|
$2.81B |
|
$2.93B |
|
71.90M |
|
| Cash Flow Statement Financials | |
$306.50M |
|
$-146.50M |
|
$-161.90M |
|
$484.60M |
|
$509.70M |
|
$25.10M |
|
$8.70M |
|
$-30.30M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.78 |
|
-- |
|
-- |
|
0.06 |
|
0.07 |
|
35.73% |
|
20.05% |
|
20.05% |
|
-- |
|
20.48% |
|
17.20% |
|
$160.00M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
1.17 |
|
1.32 |
|
68.38 |
|
|
Return on Equity |
4.50% |
4.69% |
|
3.33% |
|
4.21% |
|
$40.74 |
|
$2.21 |
|
$4.23 |
|